Biotechnology Research · Florida
Artificial Intelligence is making research faster, more accurate, and effective. Initium Bio Analytics supports biomedical professionals in the research and development of innovative medicines with our next generation technology - POMI AI™. We have engineered a cutting-edge, artificially intelligent engine that provides objective analysis of the effects of these medicines on a variety of conditions. This analysis expedites the research and development process, helping you take your product to market faster, smarter, and with confidence. Our technology has proven success with general medicine and pharmaceuticals and has assisted leading companies in the world such as Teva Pharmaceutical, Johnson & Johnson, Gamida Cell, and others. Recognizing the need for better research in the cannabinoid industry, Initium Bio adapted POMI AI™ to help drive this industry forward. We're excited to be at the forefront of a global market set to change the landscape of medical science.